BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21502437)

  • 1. Patient safety and the next generation of HPV DNA tests.
    Simon K; Kondratovich MV; Hojvat S; Gutierrez A
    Am J Clin Pathol; 2011 May; 135(5):798-9; author reply 799-803. PubMed ID: 21502437
    [No Abstract]   [Full Text] [Related]  

  • 2. Patient safety and the next generation of HPV DNA tests.
    Lee SH
    Am J Clin Pathol; 2011 Mar; 135(3):481; author reply 482-3. PubMed ID: 21350106
    [No Abstract]   [Full Text] [Related]  

  • 3. Introduction of human papillomavirus DNA screening in the world: 15 years of experience.
    Castle PE; de Sanjosé S; Qiao YL; Belinson JL; Lazcano-Ponce E; Kinney W
    Vaccine; 2012 Nov; 30 Suppl 5():F117-22. PubMed ID: 23199954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Special commentary: patient safety and the next generation of HPV DNA tests.
    Kinney W; Stoler MH; Castle PE
    Am J Clin Pathol; 2010 Aug; 134(2):193-9. PubMed ID: 20660320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cervical cancer screning: from cytology to HPV testing].
    Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):289-292. PubMed ID: 31154708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commentary on: Statement on HPV DNA test utilization.
    Cox JT; Moriarty AT; Castle PE
    J Low Genit Tract Dis; 2009 Jul; 13(3):131-4. PubMed ID: 19550208
    [No Abstract]   [Full Text] [Related]  

  • 7. The potential role of self-sampling for high-risk human papillomavirus detection in cervical cancer screening.
    Schmeink CE; Bekkers RL; Massuger LF; Melchers WJ
    Rev Med Virol; 2011 May; 21(3):139-53. PubMed ID: 21538664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV mRNA test in women with minor cervical lesions: experience of the University Hospital of North Norway.
    Sorbye SW; Fismen S; Gutteberg TJ; Mortensen ES
    J Virol Methods; 2010 Oct; 169(1):219-22. PubMed ID: 20638416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the clinical performance of high-risk human papillomavirus testing for primary screening: a retrospective review of the Southern California Permanente Medical Group experience.
    Lonky NM; Mahdavi A; Wolde-Tsadik G; Bajamundi K; Felix JC
    J Low Genit Tract Dis; 2010 Jul; 14(3):200-5. PubMed ID: 20592555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening of cervical cancer and test for HPV].
    Hirai Y
    Gan To Kagaku Ryoho; 2010 Feb; 37(2):232-5. PubMed ID: 20235390
    [No Abstract]   [Full Text] [Related]  

  • 11. New HPV test now recommended.
    AIDS Patient Care STDS; 2003 Dec; 17(12):671-2. PubMed ID: 14748367
    [No Abstract]   [Full Text] [Related]  

  • 12. [Medicine and money: detection of HPV DNA--what's the impediment?].
    Miseta A
    Orv Hetil; 2003 Dec; 144(52):2589-90. PubMed ID: 15005070
    [No Abstract]   [Full Text] [Related]  

  • 13. Adding a test for human papillomavirus DNA to cervical-cancer screening.
    Wright TC; Schiffman M
    N Engl J Med; 2003 Feb; 348(6):489-90. PubMed ID: 12571255
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The impact of natural history and genital tract distribution of human papillomavirus on technology for cervical cancer screening].
    Wu ZN; Chen W
    Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):241-5. PubMed ID: 27087368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiology of HPV infection].
    Boulanger JC; Sevestre H; Bauville E; Ghighi C; Harlicot JP; Gondry J
    Gynecol Obstet Fertil; 2004 Mar; 32(3):218-23. PubMed ID: 15123119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical performance of Invader technology and SurePath when detecting the presence of high-risk HPV cervical infection.
    Harvey M; Stout S; Starkey CR; Hendren R; Holt S; Miller GC
    J Clin Virol; 2009 Jul; 45 Suppl 1():S79-83. PubMed ID: 19651373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can the test for human papillomavirus DNA be used as the stand-alone, first-line screening test for cervical cancer?
    Jin XW; McKenzie ML; Yen-Lieberman B
    Cleve Clin J Med; 2015 Apr; 82(4):213-5. PubMed ID: 25955454
    [No Abstract]   [Full Text] [Related]  

  • 19. Statement on HPV DNA test utilization.
    Solomon D; Papillo J; Davis Davey D;
    J Low Genit Tract Dis; 2009 Jul; 13(3):135-6. PubMed ID: 19550209
    [No Abstract]   [Full Text] [Related]  

  • 20. The next-generation Hybrid Capture High-Risk HPV DNA assay on a fully automated platform.
    Eder PS; Lou J; Huff J; Macioszek J
    J Clin Virol; 2009 Jul; 45 Suppl 1():S85-92. PubMed ID: 19651374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.